CN112641803A - 一种干细胞外泌体制剂及其制备方法 - Google Patents
一种干细胞外泌体制剂及其制备方法 Download PDFInfo
- Publication number
- CN112641803A CN112641803A CN201910908545.5A CN201910908545A CN112641803A CN 112641803 A CN112641803 A CN 112641803A CN 201910908545 A CN201910908545 A CN 201910908545A CN 112641803 A CN112641803 A CN 112641803A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- preparation
- mesenchymal stem
- exosome
- umbilical cord
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001808 exosome Anatomy 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 31
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 40
- 210000003954 umbilical cord Anatomy 0.000 claims abstract description 31
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 18
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 18
- 238000012258 culturing Methods 0.000 claims abstract description 13
- 210000002889 endothelial cell Anatomy 0.000 claims abstract description 12
- 210000003606 umbilical vein Anatomy 0.000 claims abstract description 9
- 210000004027 cell Anatomy 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- 239000001963 growth medium Substances 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 10
- 238000004113 cell culture Methods 0.000 claims description 9
- 239000003636 conditioned culture medium Substances 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 8
- 238000005199 ultracentrifugation Methods 0.000 claims description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 239000012091 fetal bovine serum Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 239000004017 serum-free culture medium Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 210000003462 vein Anatomy 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 238000013508 migration Methods 0.000 abstract description 3
- 230000005012 migration Effects 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 231100000683 possible toxicity Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000004393 prognosis Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000000432 density-gradient centrifugation Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010028594 Myocardial fibrosis Diseases 0.000 description 1
- 208000033774 Ventricular Remodeling Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910908545.5A CN112641803A (zh) | 2019-09-25 | 2019-09-25 | 一种干细胞外泌体制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910908545.5A CN112641803A (zh) | 2019-09-25 | 2019-09-25 | 一种干细胞外泌体制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112641803A true CN112641803A (zh) | 2021-04-13 |
Family
ID=75342290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910908545.5A Pending CN112641803A (zh) | 2019-09-25 | 2019-09-25 | 一种干细胞外泌体制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112641803A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113081957A (zh) * | 2021-04-23 | 2021-07-09 | 广州研华生物科技有限公司 | 一种脐带间充质干细胞外泌体制剂及其制备方法 |
CN113930393A (zh) * | 2021-09-27 | 2022-01-14 | 兰州大学 | 一种脐带干细胞来源外泌体的提取及水凝胶的制备方法 |
CN114134110A (zh) * | 2021-12-13 | 2022-03-04 | 四川泊麦科技发展股份有限公司 | 一种基于超滤离心法获取外泌体的制备方法 |
CN114736855A (zh) * | 2021-12-27 | 2022-07-12 | 武汉市舍巴精准医学科技有限公司 | 一种干细胞外泌体高纯度提取方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120093885A1 (en) * | 2010-10-18 | 2012-04-19 | Northwestern University | Therapeutic vesicles |
US20160108368A1 (en) * | 2014-07-03 | 2016-04-21 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
CN105597088A (zh) * | 2016-02-02 | 2016-05-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种制剂、其制备方法及其应用 |
CN105802912A (zh) * | 2016-05-12 | 2016-07-27 | 细胞邦(北京)生物技术有限公司 | 从细胞、组织培养上清或体液中分离细胞外微囊的方法及其专用分离试剂、试剂盒与应用 |
CN109880797A (zh) * | 2019-04-08 | 2019-06-14 | 济南磐升生物技术有限公司 | 一种制备人脐带间充质干细胞外泌体的方法 |
-
2019
- 2019-09-25 CN CN201910908545.5A patent/CN112641803A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120093885A1 (en) * | 2010-10-18 | 2012-04-19 | Northwestern University | Therapeutic vesicles |
US20160108368A1 (en) * | 2014-07-03 | 2016-04-21 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
CN105597088A (zh) * | 2016-02-02 | 2016-05-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种制剂、其制备方法及其应用 |
CN105802912A (zh) * | 2016-05-12 | 2016-07-27 | 细胞邦(北京)生物技术有限公司 | 从细胞、组织培养上清或体液中分离细胞外微囊的方法及其专用分离试剂、试剂盒与应用 |
CN109880797A (zh) * | 2019-04-08 | 2019-06-14 | 济南磐升生物技术有限公司 | 一种制备人脐带间充质干细胞外泌体的方法 |
Non-Patent Citations (3)
Title |
---|
YUNTONG ZHANG等: "Exosomes from human umbilical cord mesenchymal stem cells enhance fracture healing through HIF-1α-mediated promotion of angiogenesis in a rat model of stabilized fracture", 《CELL PROLIF.》 * |
蒲双双: "外泌体的提取、鉴定和保存方法研究进展", 《现代检验医学杂志》 * |
边素艳等: "生长因子刺激的间充质干细胞释放具有很强促血管新生功能的外泌体", 《中国实验血液学杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113081957A (zh) * | 2021-04-23 | 2021-07-09 | 广州研华生物科技有限公司 | 一种脐带间充质干细胞外泌体制剂及其制备方法 |
CN113081957B (zh) * | 2021-04-23 | 2022-07-22 | 广州研华生物科技有限公司 | 一种脐带间充质干细胞外泌体制剂及其制备方法 |
CN113930393A (zh) * | 2021-09-27 | 2022-01-14 | 兰州大学 | 一种脐带干细胞来源外泌体的提取及水凝胶的制备方法 |
CN114134110A (zh) * | 2021-12-13 | 2022-03-04 | 四川泊麦科技发展股份有限公司 | 一种基于超滤离心法获取外泌体的制备方法 |
CN114134110B (zh) * | 2021-12-13 | 2024-03-26 | 四川泊麦科技发展股份有限公司 | 一种基于超滤离心法获取外泌体的制备方法 |
CN114736855A (zh) * | 2021-12-27 | 2022-07-12 | 武汉市舍巴精准医学科技有限公司 | 一种干细胞外泌体高纯度提取方法 |
CN114736855B (zh) * | 2021-12-27 | 2024-03-01 | 武汉市舍巴精准医学科技有限公司 | 一种干细胞外泌体高纯度提取方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112641803A (zh) | 一种干细胞外泌体制剂及其制备方法 | |
Nagamura-Inoue et al. | Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility | |
CN106982821A (zh) | 脐带间充质干细胞临床冻存保护液组合物及其用途 | |
AU2013284340B2 (en) | Isolation of stem cells from adipose tissue by ultrasonic cavitation, and methods of use | |
CN109536440A (zh) | 外泌体的提取方法 | |
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
CN110564682B (zh) | 一种大规模生产人脂肪间充质干细胞外泌体的方法 | |
US20220325247A1 (en) | METHOD FOR PROMOTING GROWTH OF PARIETAL DECIDUAL BASALIS-MESENCHYMAL STEM CELLS (PDB-MSCs) | |
SG181774A1 (en) | Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue | |
CN102154200B (zh) | 临床治疗用脐带间充质干细胞的制备和保存 | |
CN103421739B (zh) | 一种高效分离脐带间充质干细胞的方法 | |
CN105647860A (zh) | 临床治疗级人胎盘底蜕膜来源的间充质干细胞(PDB-MSCs)无血清体外提取制备方法 | |
CN111088226A (zh) | 一种胎盘间充质干细胞外泌体的制备和储存方法 | |
CN105713869A (zh) | 回输临床治疗用人胎盘叶状绒毛膜来源的间充质干细胞体外三维分离培养保存方法 | |
CN114276980B (zh) | 一种培养适合临床应用的胰岛细胞的方法 | |
CN115386542B (zh) | 工程化的鹿茸干细胞外泌体和制备方法、及在骨肉瘤治疗中的应用 | |
CN105695401A (zh) | 一种脐带动脉和静脉血管周干细胞的制备和保存方法 | |
CN203625386U (zh) | 一种用于分离和培养脐带间充质干细胞的试剂盒 | |
CN111617105A (zh) | 一种脂肪干细胞多细胞活性因子冻干粉的制备方法 | |
CN110885784A (zh) | 一种临床应用级脂肪干细胞及其制备方法 | |
JP2020063192A (ja) | 真皮線維芽細胞の培養上清液を含む化粧用組成物およびその製造方法 | |
CN105147722A (zh) | 硫酸化白芨多糖的新用途及一种治疗眼表损伤的制剂 | |
RU2398873C1 (ru) | Способ получения препаратов для медицинских целей | |
CN114540296B (zh) | 一种复合外泌体的制备方法及其在定向增强血管生成能力方面的应用 | |
WO2018179374A1 (ja) | 真皮線維芽細胞の培養上清液を含む化粧用組成物およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220817 Address after: 13th Floor, Block A, Tellus Shuibei Jewelry Building, Northwest Side, No. 38, Shuibei 2nd Road, Cuijin Community, Cuizhu Street, Luohu District, Shenzhen, Guangdong 518000 Applicant after: Sinopoly Biotechnology (Guangdong) Group Co., Ltd. Address before: 518000 11th floor, No.2 workshop, Daqian industrial plant, 67 District, Xin'an street, Bao'an District, Shenzhen City, Guangdong Province Applicant before: SHENZHEN GUANGCAI LIFE ENGINEERING TECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210413 |
|
RJ01 | Rejection of invention patent application after publication |